Clinical trial
Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma
NCT00297141 · Austrian Breast & Colorectal Cancer Study Group, Other · Completed
Key facts
| NCT number | NCT00297141 |
|---|---|
| Title | Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma |
| Official title | Preoperative Combined Radiochemotherapy for Patients With Newly Diagnosed, Primary Operable and Locally Advanced Rectal Carcinoma (cT3, Nx, M0) of the Lower and Middle Rectum |
| Lead sponsor | Austrian Breast & Colorectal Cancer Study Group, Other |
| Collaborators | Sanofi-Synthelabo Industry Hoffmann-La Roche |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rectal Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine, Oxaliplatin |
| Enrollment | 60 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Feb 28, 2006 |
| Last update posted | Dec 31, 2013 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: